Home > Boards > US Listed > Medical - Drugs > Oramed Pharmaceuticals (ORMP)

FMELLO—- thank you very much for posting this.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
ranchhand71 Member Profile
 
Followed By 5
Posts 718
Boards Moderated 0
Alias Born 12/22/17
160x600 placeholder
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/16/2021 4:09:44 PM
Registration of Additional Securities (up to 20%) (s-3mef) Edgar (US Regulatory) - 6/16/2021 9:37:50 AM
Oramed Reaches 50% Enrollment in Phase 3 Oral Insulin Study PR Newswire (US) - 6/8/2021 8:10:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/25/2021 4:06:12 PM
Oramed Issues Letter to Shareholders with Updates on Oral Insulin and COVID-19 Vaccine PR Newswire (US) - 5/25/2021 8:40:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/10/2021 4:16:04 PM
Oramed Pharmaceuticals and Oravax Medical to be Featured in Alliance Global Partners' Grand Rounds: A Webinar in Biotech and ... PR Newswire (US) - 4/21/2021 7:25:00 AM
Oramed Pharma initiated buy at Cantor citing the potential of oral insulin therapy Seeking Alpha - 4/20/2021 3:59:21 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/13/2021 4:20:14 PM
Oramed initiates second phase 3 study of oral insulin candidate; shares up 14% Seeking Alpha - 3/23/2021 9:39:49 AM
Oramed Initiates Second Phase 3 Oral Insulin Study Under the FDA's Approved Dual Concurrent Protocol PR Newswire (US) - 3/23/2021 8:51:00 AM
ORMP, MOGO, LIZI and LEAF among premarket gainers Seeking Alpha - 3/23/2021 8:23:50 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/23/2021 7:37:27 AM
Premas Biotech et Oramed annoncent un vaccin candidat oral contre la COVID-19 qui produit des anticorps après une seule dose Business Wire - 3/22/2021 3:06:00 AM
Premas Biotech and Oramed Announce Oral COVID-19 Vaccine Candidate That Produces Antibodies After a Single Dose Business Wire - 3/19/2021 10:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/19/2021 9:07:51 AM
Oramed to form Oravax Medical JV to develop oral COVID-19 vaccines Seeking Alpha - 3/19/2021 8:48:31 AM
Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 Vaccines PR Newswire (US) - 3/19/2021 8:40:00 AM
Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 Vaccines PR Newswire (US) - 3/19/2021 8:40:00 AM
Oramed reaches 25% enrollment in late-stage ORMD-0801 study Seeking Alpha - 3/16/2021 8:43:28 AM
Oramed Reaches 25% Randomization in World's First Phase 3 Oral Insulin Study Conducted Under FDA Approved Protocol PR Newswire (US) - 3/16/2021 8:25:00 AM
Oramed to Present at H.C. Wainwright Global Life Sciences Conference 2021 PR Newswire (US) - 3/4/2021 8:25:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 4:13:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/17/2021 4:22:33 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 2/11/2021 6:08:27 AM
ranchhand71   Wednesday, 04/28/21 07:47:24 PM
Re: Fmello post# 816
Post # of 879 
FMELLO—- thank you very much for posting this. Any chance you may be able to post recent Canaccord report.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences